CD8A and neoplasm: The persistence of CD8+ cells and, to lesser extent, NK cells in tumors over 20 days after mpJX+aPD1 (Figures 3D and 3F) accompanied an 85% suppression of tumor cell proliferation despite no vaccinia staining and a baseline level of apoptosis (Figures 1E and 3B).